Piezo1-Mediated Mechanotransduction in Cancer: A Comprehensive Up-to-Date Review of Emerging Mechanistic and Therapeutic Insights

Authors

  • Parisa Beyranvand Department of Industrial and Environmental Biotechnology, National Institute of Genetic Engineering and Biotechnology (NIGEB), Tehran, Iran

Keywords:

Piezo1, Mechanotransduction, Tumor microenvironment, Cancer progression, Therapeutic targeting

Abstract

Mechanical forces have emerged as key determinants of cancer progression, influencing cellular behavior, tumor architecture, and therapeutic response. Among mechanosensitive molecules, the ion channel Piezo1 functions as a central transducer that converts physical cues - such as extracellular matrix (ECM) stiffness, compression, and shear stress - into biochemical signals that reshape tumor cell fate. Accumulating evidence indicates that Piezo1 exerts dualistic, context-dependent roles in cancer, promoting either tumor progression or cell death depending on the mechanical landscape, tissue context, and metabolic state. Rather than focusing solely on its molecular interactions, this review provides an integrative overview of Piezo1’s context-dependent roles across diverse malignancies, including breast, ovarian, cervical, hepatocellular, gastric, colorectal, pancreatic, and brain cancers. In each setting, Piezo1 governs distinct aspects of tumor biology - ranging from epithelial - mesenchymal transition (EMT), angiogenesis, and metabolic adaptation to immune evasion and therapy resistance-through Ca²⁺ - dependent mechanotransduction. Experimental and clinical studies consistently identify PIEZO1 overexpression as a marker of poor prognosis and metastatic potential, while genetic silencing or pharmacologic modulation alters invasion, apoptosis, or ferroptosis in a tumor-type-specific manner. By consolidating evidence from structural, cellular, and translational studies, this review delineates how Piezo1 acts as a mechanobiological hub that interprets the physical landscape of the tumor microenvironment. These findings position Piezo1 as both a mechanobiological biomarker and a therapeutically actionable target whose functional impact is dictated by tissue mechanics, malignant lineage, and the surrounding microenvironmental context.

Downloads

Download data is not yet available.

References

Dombroski JA, Hope JM, Sarna NS, King MR. Channeling the force: Piezo1 mechanotransduction in cancer metastasis. Cells. 2021, 10(11), 2815. DOI: 10.3390/cells10112815

Zhao F, Zhang L, Wei M, Duan W, Wu S, Kasim V. Mechanosensitive ion channel PIEZO1 signaling in the hall-marks of cancer: structure and functions. Cancers (Basel). 2022, 14(19), 4955. DOI: 10.3390/cancers14194955

Micek HM, Yang N, Dutta M, Rosenstock L, Ma Y, Hielsberg C, et al. The role of Piezo1 mechanotransduction in high-grade serous ovarian cancer: Insights from an in vitro model of collective detachment. Science Advances. 2024, 10(17), eadl4463. DOI: 10.1126/sciadv.adl4463

Wang Y, Zhang Z, Yang Q, Cao Y, Dong Y, Bi Y, et al. Immunoregulatory role of the mechanosensitive ion channel Piezo1 in inflammation and cancer. Molecules. 2022, 28(1), 213. DOI: 10.3390/molecules28010213

Kim YJ, Hyun J. Mechanosensitive ion channels in apoptosis and ferroptosis: focusing on the role of Piezo1. BMB Reports. 2023, 56(2), 145-152. DOI: 10.5483/BMBRep.2023-0002

Zhang Y, Zou W, Dou W, Luo H, Ouyang X. Pleiotropic physiological functions of Piezo1 in human body and its effect on malignant behavior of tumors. Frontiers in Physiology. 2024, 15, 1377329. DOI: 10.3389/fphys.2024.1377329

Dai Y, Liu Y, An L, Zhong F, Zhang X, Lou S. Afatinib boosts CAR-T cell antitumor therapeutic efficacy via metabolism and fate reprogramming. Journal for Immunotherapy of Cancer. 2024, 12(11), e009949. DOI: 10.1136/jitc-2024-009949

Pardo-Pastor C, Rosenblatt J. Piezo1 activates noncanonical EGFR endocytosis and signaling. Science Advances. 2023, 9(39), eadi1328. DOI: 10.1126/sciadv.adi1328

Poole RA, Wang Q, Ray A, Takabe K, Opyrchal M, Katsuta E. Increased PIEZO1 expression is associated with worse clinical outcomes in hormone-receptor-negative breast cancer patients. Cancers. 2024, 16(4), 683. DOI: 10.3390/cancers16040683

Lonez C, Bolsée J, Huberty F, Nguyen T, Jacques-Hespel C, Anguille S, et al. Clinical proof-of-concept of a non-gene editing technology using miRNA-based shRNA to engineer allogeneic CAR T-Cells. International Journal of Molecular Sciences. 2025, 26(4), 1658. DOI: 10.3390/ijms26041658

Han Y, Liu C, Zhang D, Men H, Huo L, Geng Q, et al. Mechanosensitive ion channel Piezo1 promotes prostate cancer development through the activation of the Akt/mTOR pathway and acceleration of cell cycle. International Journal of Oncology. 2019, 55(3), 629-644. DOI: 10.3892/ijo.2019.4839

Bo H, Wu Q, Zhu C, Zheng Y, Cheng G, Cui L. PIEZO1 acts as a cancer suppressor by regulating the ROS/Wnt/β‐catenin axis. Thoracic Cancer. 2024, 15(12), 1007-1016. DOI: 10.1111/1759-7714.15278

Zhao Q, Zhou H, Chi S, Wang Y, Wang J, Geng J, et al. Structure and mechanogating mechanism of the Piezo1 channel. Nature. 2018, 554(7693), 487-492. DOI: 10.1038/nature25743

Li DJ, Song YY, Zeng Y, Hu H, Tian W. Research progress on PIEZO1 protein structure and activation mechanism by small-molecule agonists. Results in Chemistry. 2025, 102058. DOI: 10.1016/j.rechem.2025.102058

Jiang Y, Yang X, Jiang J, Xiao B. Structural designs and mechanogating mechanisms of the mechanosensitive Piezo channels. trends in biochemical sciences. 2021, 46(6), 472-488. DOI: 10.1016/j.tibs.2021.01.008

Guo YR, MacKinnon R. Structure-based membrane dome mechanism for Piezo mechanosensitivity. Elife. 2017, 6, e33660. DOI: 10.7554/eLife.33660

Zhao Q, Zhou H, Li X, Xiao B. The mechanosensitive Piezo1 channel: a three-bladed propeller-like structure and a lever-like mechanogating mechanism. The FEBS Journal. 2019, 286(13), 2461-2470. DOI: 10.1111/febs.14711

Shan Y, Guo X, Zhang M, Chen M, Li Y, Zhang M, et al. Structure of human PIEZO1 and its slow-inactivating channelopathy mutants. Elife. 2025, 13, RP101923. DOI: 10.7554/eLife.101923

Rode B, Shi J, Endesh N, Drinkhill MJ, Webster PJ, Lotteau SJ, et al. Piezo1 channels sense whole body physical activity to reset cardiovascular homeostasis and enhance performance. Nature Communications. 2017, 8(1), 350. DOI: 10.1038/s41467-017-00429-3

Cox CD, Bae C, Ziegler L, Hartley S, Nikolova-Krstevski V, Rohde PR, et al. Removal of the mechanoprotective influence of the cytoskeleton reveals PIEZO1 is gated by bilayer tension. Nature Communications. 2016, 7(1), 10366. DOI: 10.1038/ncomms10366

Qi Y, Andolfi L, Frattini F, Mayer F, Lazzarino M, Hu J. Membrane stiffening by STOML3 facilitates mechanosensation in sensory neurons. Nature Communications. 2015, 6(1), 8512. DOI: 10.1038/ncomms9512

Sheth M, Sharma M, Esfandiari L. Matrix stiffness-induced Piezo1 activation promotes metastatic potential in three-dimensional head and neck cancer spheroids. Biophysical Journal. 2024, 123(3), 406a. DOI: 10.1016/j.bpj.2023.11.2490

Emig R, Knodt W, Krussig MJ, Zgierski-Johnston CM, Gorka O, Groß O, et al. Piezo1 channels contribute to the regulation of human atrial fibroblast mechanical properties and matrix stiffness sensing. Cells. 2021, 10(3), 663. DOI: 10.3390/cells10030663

Verkest C, Lechner SG. Advances and recent insights into the gating mechanisms of the mechanically activated ion channels PIEZO1 and PIEZO2. Current Opinion in Physiology. 2023, 31, 100625. DOI: 10.1016/j.cophys.2022.100625

Mazal H, Wieser FF, Bollschweiler D, Schambony A, Sandoghdar V. Cryo–light microscopy with angstrom precision deciphers structural conformations of PIEZO1 in its native state. Science Advances. 2025, 11(34), eadw4402. DOI: 10.1126/sciadv.adw4402

Vasileva V, Chubinskiy-Nadezhdin V. Regulation of PIEZO1 channels by lipids and the structural components of extracellular matrix/cell cytoskeleton. Journal of Cellular Physiology. 2023, 238(5), 918-930. DOI: 10.1002/jcp.31001

Sugimoto A, Iwata K, Kurogoushi R, Tanaka M, Nakashima Y, Yamakawa Y, et al. C-terminus of PIEZO1 governs Ca(2+) influx and intracellular ERK1/2 signaling pathway in mechanotransduction. Biochemical and Biophysical Research Communications. 2023, 682, 39-45. DOI: 10.1016/j.bbrc.2023.09.080

Wu XT, Sun LW, Yang X, Ding D, Han D, Fan YB. The potential role of spectrin network in the mechanotransduction of MLO-Y4 osteocytes. Scientific Reports. 2017, 7(1), 40940. DOI: 10.1038/srep40940

Zhang M, Tang S, Wang X, Fang S, Li Y. Mechanosensitive channel MscL gating transitions coupling with constriction point shift. Protein Science. 2024, 33(4), e4965. DOI: 10.1002/pro.4965

Moller E, Britt M, Anishkin A, Yoshimura K, Zhou F, Matthies D, et al. In search of a compact closed conformation of bacterial mechanosensitive channel MscS. Biophysical Journal. 2024, 123(3), 211a-212a. DOI: 10.1016/j.bpj.2023.11.1335

Bass RB, Strop P, Barclay M, Rees DC. Crystal structure of Escherichia coli MscS, a voltage-modulated and mechanosensitive channel. Science (New York, N.Y.). 2002, 298(5598), 1582-7. DOI: 10.1126/science.1077945

Kinsella JA, Debant M, Parsonage G, Morley LC, Bajarwan M, Revill C, et al. Pharmacology of PIEZO1 channels. British Journal of Pharmacology. 2024, 181(23), 4714-4732. DOI: 10.1111/bph.17351

Coste B, Mathur J, Schmidt M, Earley TJ, Ranade S, Petrus MJ, et al. Piezo1 and Piezo2 are essential components of distinct mechanically activated cation channels. Science (New York, N.Y.). 2010, 330(6000), 55-60. DOI: 10.1126/science.1193270

Sukharev SI, Blount P, Martinac B, Blattner FR, Kung C. A large-conductance mechanosensitive channel in E. coli encoded by mscL alone. Nature. 1994, 368(6468), 265-8. DOI: 10.1038/368265a0

Schneider DM, Nelson A, Mooney R. A synaptic and circuit basis for corollary discharge in the auditory cortex. Nature. 2014, 513(7517), 189-194. DOI: 10.1038/nature13724

Mierke CT. Extracellular matrix cues regulate mechanosensing and mechanotransduction of cancer cells. Cells. 2024, 13(1), 96. DOI: 10.3390/cells13010096

Yao M, Qiu W, Liu R, Efremov AK, Cong P, Seddiki R, et al. Force-dependent conformational switch of α-catenin controls vinculin binding. Nature Communications. 2014, 5(1), 4525. DOI: 10.1038/ncomms5525

De Felice D, Alaimo A. Mechanosensitive Piezo channels in cancer: focus on altered calcium signaling in cancer cells and in tumor progression. Cancers (Basel). 2020, 12(7), 1780. DOI: 10.3390/cancers12071780

Migulina N. Mechanisms and consequences of disturbed crosstalk between cells and extracellular matrix in COPD. University of Groningen. 2024. DOI: 10.33612/diss.881547816

Xing H, Liu H, Chang Z, Zhang J. Research progress on the immunological functions of Piezo1 a receptor molecule that responds to mechanical force. International Immunopharmacology. 2024, 139, 112684. DOI: 10.1016/j.intimp.2024.112684

Xu H, Chen Z, Li C. The prognostic value of Piezo1 in breast cancer patients with various clinicopathological features. Anti-Cancer Drugs. 2021, 32(4), 448-455. DOI: 10.1097/CAD.0000000000001049

Li C, Rezania S, Kammerer S, Sokolowski A, Devaney T, Gorischek A, et al. Piezo1 forms mechanosensitive ion channels in the human MCF-7 breast cancer cell line. Scientific Reports. 2015, 5(1), 8364. DOI: 10.1038/srep08364

Ouyang M, Chen W, Zhou T, Liu H, Liu L, Bu B, et al. The underlying difference of metastatic and non-metastatic breast cancer cells in configuring type I collagen fibres to promote migration by cell mechanics. Mechanobiology in Medicine. 2025, 3(2), 100113. DOI: 10.1016/j.mbm.2025.100113

Yu Y, Wu X, Liu S, Zhao H, Li B, Zhao H, et al. Piezo1 regulates migration and invasion of breast cancer cells via modulating cell mechanobiological properties. Acta Biochimica et Biophysica Sinica. 2021, 53(1), 10-18. DOI: 10.1093/abbs/gmaa112

Weng Y, Yan F, Chen R, Qian M, Ou Y, Xie SH, et al. PIEZO channel protein naturally expressed in human breast cancer cell MDA-MB-231 as probed by atomic force microscopy. AIP Advances. 2018, 8(5), 055101. DOI: 10.1063/1.5025036

So CL, Robitaille M, Sadras F, McCullough MH, Milevskiy MJG, Goodhill GJ, et al. Cellular geometry and epithelial-mesenchymal plasticity intersect with PIEZO1 in breast cancer cells. Communications Biology. 2024, 7(1), 467. DOI: 10.1038/s42003-024-06163-z

O'Callaghan P, Engberg A, Eriksson O, Fatsis-Kavalopoulos N, Stelzl C, Sanchez G, et al. Piezo1 activation attenuates thrombin-induced blebbing in breast cancer cells. Journal of Cell Science. 2022, 135(7), jcs258809. DOI: 10.1242/jcs.258809

Marino A, Battaglini M, De Pasquale D, Degl'Innocenti A, Ciofani G. Ultrasound-activated Piezoelectric nanoparticles inhibit proliferation of breast cancer cells. Scientific Reports. 2018, 8(1), 6257. 10.1038/s41598-018-24697-1

Li BH, Chen ZC, Zhang ZY, Liu H, Han DL, Yang HL, et al. Zuogui pill disrupt the malignant cycle in breast cancer bone metastasis through the Piezo1-Notch-1-GPX4 pathway and active molecules fishing. Phytomedicine. 2024, 123, 155257. DOI: 10.1016/j.phymed.2023.155257

Katsuta E, Takabe K, Vujcic M, Gottlieb PA, Dai T, Mercado-Perez A, et al. Mechano-sensing channel PIEZO2 enhances invasive phenotype in triple-negative breast cancer. International Journal of Molecular Sciences. 2022, 23(17), 9909. DOI: 10.3390/ijms23179909

Lou WY, Liu JX, Ding BS, Jin LQ, Xu L, Li X, et al. Five miRNAs-mediated PIEZO2 downregulation, accompanied with activation of Hedgehog signaling pathway, predicts poor prognosis of breast cancer. Aging. 2019, 11(9), 2628-2652. DOI: 10.18632/aging.101934

Martín-Sanz R, Rodrigues-Françoso A, García-Mesa Y, García-Alonso FJ, Gómez-Muñoz MA, Malmierca-González S, et al. Prognostic evaluation of Piezo2 channels in mammary gland carcinoma. Cancers. 2024, 16(13), 2413. DOI: 10.3390/cancers16132413

Xiong YJ, Dong LR, Bai Y, Tang H, Li S, Luo D, et al. Piezo1 activation facilitates ovarian cancer metastasis via Hippo/YAP signaling axis. Channels (Austin, Tex.). 2022, 16(1), 159-166. DOI: 10.1080/19336950.2022.2099381

Li Y, Zhou F, Xu ZM. TRIM25 facilitates ferroptosis in ovarian cancer through promoting PIEZO1 K63-linked ubiquitination and degradation. Translational Oncology. 2025, 56, 102386. DOI: 10.1016/j.tranon.2025.102386

Karasová M, Jobst M, Framke D, Bergen J, Meier-Menches S, Keppler B, et al. Mechanical cues rewire lipid metabolism and support chemoresistance in epithelial ovarian cancer cell lines OVCAR3 and SKOV3. Cell Communication and Signaling. 2025, 23(1), 193. DOI: 10.1186/s12964-025-02144-9

Zhang L, Wang L, Wang M, Peng KF, Chen HH, Wang X, et al. Identification of mechanosensitive ion channel-related molecular subtypes and key genes for ovarian cancer. Translational Cancer Research. 2025, 14(8), 5166-5175. DOI: 10.21037/tcr-2025-1219

Jin JQ, Fan ZF, Long YL, Li YP, He Q, Yang YM, et al. Matrine induces ferroptosis in cervical cancer through activation of Piezo1 channel. Phytomedicine. 2024, 122, 155165. DOI: 10.1016/j.phymed.2023.155165

Liao WX, Li Y, Liu TT, Deng JX, Liang H, Shen FJ. The activation of Piezo1 channel promotes invasion and migration via the release of extracellular ATP in cervical cancer. Pathology, Research and Practice. 2024, 260, 155426. DOI: 10.1016/j.prp.2024.155426

Liu TT, Liang H, Li Y, Liao WX, Deng JX, Zhang LY, et al. The increased matrix stiffness caused by LOXL2 activates Piezo1 channels to promote the migration and invasion of cervical cancer cells. Discover Oncology. 2025, 16(1), 644. DOI: 10.1007/s12672-025-02456-9

Rose L, Krishna S. Live cell extrusion in cervical cancer - a novel mechanism for cancer progression. bioRxiv. 2025. DOI: 10.1101/2025.05.13.653891

Li M, Zhang X, Wang MM, Wang YH, Qian JL, Xing XX, et al. Activation of Piezo1 contributes to matrix stiffness-induced angiogenesis in hepatocellular carcinoma. Cancer Communications. 2022, 42(11), 1162-1184. DOI: 10.1002/cac2.12364

Zhang X, Zhao YY, Li M, Wang MM, Qian JL, Wang ZM, et al. A synergistic regulation works in matrix stiffness-driven invadopodia formation in HCC. Cancer Letters. 2024, 582, 216597. DOI: 10.1016/j.canlet.2023.216597

Liu SL, Xu XH, Fang ZG, Ning YL, Deng B, Pan XM, et al. Piezo1 impairs hepatocellular tumor growth via deregulation of the MAPK-mediated YAP signaling pathway. Cell Calcium. 2021, 95, 102367. DOI: 10.1016/j.ceca.2021.102367

Mo JF, Zhang YX, Cao CX, Zheng WL, Zheng L, Wang XG, et al. Activation of mechanosensitive ion channel Piezo1 linking metabolic reprogramming and pro-inflammatory responses in hepatocellular carcinoma. Cell Communication and Signaling. 2025, 23(1), 280. DOI: 10.1186/s12964-025-02289-7

Andolfo I, Rosato BE, Manna F, De Rosa G, Marra R, Gambale A, et al. Gain-of-function mutations in PIEZO1 directly impair hepatic iron metabolism via the inhibition of the BMP/SMADs pathway. American Journal of Hematology. 2020, 95(2), 188-197. DOI: 10.1002/ajh.25683

Yu HQ, Zhang YJ, Shuai L, Peng C, Zhao CC, Jiang Y, et al. Low hepatic artery blood flow mediates NET extravasation through the regulation of PIEZO1/SRC signaling to induce biliary complications after liver transplantation. Theranostics. 2024, 14(17), 6783-6797. DOI: 10.7150/thno.99514

Ye XS, Xia YJ, Zheng YL, Chen W, Chen ZM, Cheng Z, et al. The function of Piezo1 in hepatoblastoma metastasis and its potential transduction mechanism. Heliyon. 2022, 8(9), e10301. DOI: 10.1016/j.heliyon.2022.e10301

Fang CK, Liu SL, Zhang SJ, Zheng H, Fang G, Chen CY, et al. Jianpi Huayu decoction enhances the antitumor effect of doxorubicin via Piezo1-mediated autophagy in hepatocellular carcinoma. Phytomedicine. 2025, 143, 156908. DOI: 10.1016/j.phymed.2025.156908

Fan YN, An CZL, Wang ZH, Luo J, Wang WB, Luo Q, et al. Matrix stiffening induces hepatocyte functional impairment and DNA damage via the Piezo1‒ERK1/2 signaling pathway. Journal of Physiology and Biochemistry. 2025, 81(2), 273-289. DOI: 10.1007/s13105-025-01070-1

Zhang JL, Zhou YH, Huang TT, Wu F, Liu LP, Kwan JSH, et al. PIEZO1 functions as a potential oncogene by promoting cell proliferation and migration in gastric carcinogenesis. Molecular Carcinogenesis. 2018, 57(9), 1144-1155. DOI: 10.1002/mc.22831

Wang XF, Cheng G, Miao Y, Qiu FY, Bai LG, Gao ZF, et al. Piezo type mechanosensitive ion channel component 1 facilitates gastric cancer omentum metastasis. Journal of Cellular and Molecular Medicine. 2021, 25(4), 2238-2253. DOI: 10.1111/jcmm.16217

Chen BN, Liu XL, Yu PY, Xie FD, Kwan JSH, Chan WN, et al. H. pylori-induced NF-κB-PIEZO1-YAP1-CTGF axis drives gastric cancer progression and cancer-associated fibroblast-mediated tumour microenvironment remodelling. Clinical and Translational Medicine. 2023, 13(11), e1481. DOI: 10.1002/ctm2.1481

Sun YH, Li M, Liu GJ, Zhang X, Zhi LH, Zhao J, et al. The function of Piezo1 in colon cancer metastasis and its potential regulatory mechanism. Journal of Cancer Research and Clinical Oncology. 2020, 146(5), 1139-1152. DOI: 10.1007/s00432-020-03179-w

Greenlee JD, Liu K, Lopez-Cavestany M, King MR. Piezo1 mechano-activation is augmented by resveratrol and differs between colorectal cancer cells of primary and metastatic origin. Molecules. 2022, 27(17), 5430. DOI: 10.3390/molecules27175430

Li R, Wang DM, Li HJ, Lei XH, Liao WL, Liu XY. Identification of Piezo1 as a potential target for therapy of colon cancer stem-like cells. Discover Oncology. 2023, 14(1), 95. DOI: 10.1007/s12672-023-00712-4

van der Net MC, Vliem MJ, Kemp LJS, Perez-Gonzalez C, Haddad TS, Strating EA, et al. Mechanosensitive calcium channels and integrins coordinate the reprogramming of colorectal cancer cells into a fetal-like state. Cell Reports. 2025, 44(10), 116308. DOI: 10.1016/j.celrep.2025.116308

Pang RY, Sun WH, Yang YY, Wen DH, Lin F, Wang DD, et al. PIEZO1 mechanically regulates the antitumour cytotoxicity of T lymphocytes. Nature Biomedical Engineering. 2024, 8(9), 1162-1176. DOI: 10.1038/s41551-024-01188-5

Liu X, Jia YP, Wang ZH, Zhang ZX, Fu WH. A pan-cancer analysis reveals the genetic alterations and immunotherapy of Piezo2 in human cancer. Frontiers in Genetics. 2022, 13, 918977. DOI: 10.3389/fgene.2022.918977

Sonkodi B. It is time to consider the lost battle of microdamaged Piezo2 in the context of E. coli and early-onset colorectal cancer. International Journal of Molecular Sciences. 2025, 26(15), 7160. DOI: 10.3390/ijms26157160

Romac JM, Shahid RA, Swain SM, Vigna SR, Liddle RA. Piezo1 is a mechanically activated ion channel and mediates pressure induced pancreatitis. Nature Communications. 2018, 9(1), 1715. DOI: 10.1038/s41467-018-04194-9

Zhu Z, Li W, Gong MY, Wang L, Yue YY, Qian WK, et al. Piezo1 act as a potential oncogene in pancreatic cancer progression. Life Sciences. 2022, 310, 121035. DOI: 10.1016/j.lfs.2022.121035

Swain SM, Romac JM, Vigna SR, Liddle RA. Piezo1-mediated stellate cell activation causes pressure-induced pancreatic fibrosis in mice. JCI Insight. 2022, 7(8), e158288. DOI: 10.1172/jci.insight.158288

Budde I, Schlichting A, Ing D, Schimmelpfennig S, Kuntze A, Fels B, et al. Piezo1-induced durotaxis of pancreatic stellate cells depends on TRPC1 and TRPV4 channels. Journal of Cell Science. 2025, 138(8), jcs263846. DOI: 10.1242/jcs.263846

Pan HP, Zhang X, Zhu SJ, Zhu BW, Wu D, Yan JS, et al. Piezo1 mediates glycolysis-boosted pancreatic ductal adenocarcinoma chemoresistance within a biomimetic three-dimensional matrix stiffness. ACS Biomaterials Science & Engineering. 2024, 10(12), 7632-7646. DOI: 10.1021/acsbiomaterials.4c01319

Song Y, Chen JF, Zhang C, Xin L, Li QY, Liu YJ, et al. Mechanosensitive channel Piezo1 induces cell apoptosis in pancreatic cancer by ultrasound with microbubbles. iScience. 2022, 25(2), 103733. DOI: 10.1016/j.isci.2022.103733

Chen N, Zhang XY, Yang P, He XM. Inhibition of autophagy promotes ultrasound‑targeted microbubble destruction-induced apoptosis of pancreatic cancer cells. International Journal of Medical Sciences. 2025, 22(7), 1708-1719. DOI: 10.7150/ijms.106509

Kuntze A, Goetsch O, Fels B, Najder K, Unger A, Wilhelmi M, et al. Protonation of Piezo1 impairs cell-matrix interactions of pancreatic stellate cells. Frontiers in Physiology. 2020, 11, 89. DOI: 10.3389/fphys.2020.00089

Xie WY, Yu X, Yang QX, Ke NW, Wang P, Kong H, et al. The immunomechanical checkpoint PYK2 governs monocyte-to-macrophage differentiation in pancreatic cancer. Cancer Discovery. 2025, 15(8), 1740-1765. DOI: 10.1158/2159-8290.CD-24-1712

Zhang T, Li Y, Cheng B, Xu Z, Liu MJ, Feng JT, et al. Piezo1 activation improves NSCLC liver metastasis immunotherapy by overriding matrix stiffness-mediated bimodal PD-L1/CXCL10 regulation. Advanced Science. 2025, 12(32), e01335. DOI: 10.1002/advs.202501335

Huang ZC, Sun ZQ, Zhang XY, Niu K, Wang Y, Zheng J, et al. Loss of stretch-activated channels, PIEZOs, accelerates non-small cell lung cancer progression and cell migration. Bioscience Reports. 2019, 39(3), BSR20181679. DOI: 10.1042/BSR20181679

Jia XL, Zhao L, Bai JC, Wen L, Meng QY, Wang HK, et al. Stiff matrix promotes lung cancer cell migration through down-regulating the Piezo1 channel expression to facilitate Ca2+-dependent filopodia formation. Materials Today. 2025. DOI: 10.2139/ssrn.5229061

Zhou M, Jiang J, Cai K, Ma SC. MA16.05 PIEZO1+ Caner-associated Fibroblasts Shape an Inert Microenvironment to Suppress Anticancer Immunity in Non-Small Cell Lung Cancer. Journal of Thoracic Oncology. 2024, 19(10), S122. DOI: 10.1016/j.jtho.2024.09.219

Duan LD, Zhao M, Wei HQ, Dong W, Bi XM, Ang L, et al. Bioinformatics analysis of the association between miR-942-5p–induced downregulation of PIEZO-type mechanosensitive ion channel component 1 and poor prognosis in non–small cell lung cancer mediated by the mitogen-activated protein kinase pathway signaling pathway. Oncology and Translational Medicine. 2024, 10(6), 272-280. DOI: 10.1097/ot9.0000000000000060

Xiong HY, Yang J, Guo J, Ma AJ, Wang B, Kang Y. Mechanosensitive Piezo channels mediate the physiological and pathophysiological changes in the respiratory system. Respiratory Research. 2022, 23(1), 196. DOI: 10.1186/s12931-022-02122-6

Kim OH, Choi YW, Park JH, Hong SA, Hong M, Chang IH, et al. Fluid shear stress facilitates prostate cancer metastasis through Piezo1-Src-YAP axis. Life Sciences. 2022, 308, 120936. DOI: 10.1016/j.lfs.2022.120936

Lopez-Cavestany M, Hahn SB, Hope JM, Reckhorn NT, Greenlee JD, Schwager SC, et al. Matrix stiffness induces epithelial-to-mesenchymal transition via Piezo1-regulated calcium flux in prostate cancwe cells. iScience. 2023, 26(4), 106275. DOI: 10.1016/j.isci.2023.106275

Fabiano AR, Newman MW, Dombroski JA, Rowland SJ, Knoblauch SV, Kusunose J, et al. Applying ultrasound to mechanically and noninvasively sensitize prostate tumors to TRAIL-mediated apoptosis. Advanced Science. 2025, 12(15), 2412995. DOI: 10.1002/advs.202412995

Seaman K, Lin CY, Song X, Sassi A, Du WW, Yang B, et al. Mechanical loading of osteocytes via oscillatory fluid flow regulates early-stage PC-3 prostate cancer metastasis to bone. Advanced Biology. 2025, 9(4), 2400824. DOI: 10.1002/adbi.202400824

Antosik P, Szachniewicz M, Baran M, Bonowicz K, Jerka D, Motylewska E, et al. Piezo-type mechanosensitive ion channel component 1 (PIEZO1) as a potential prognostic marker in renal clear cell carcinoma. International Journal of Molecular Sciences. 2025, 26(14), 6598. DOI: 10.3390/ijms26146598

Zhu BQ, Li F, Yu JJ, Liang ZL, Ke XW, Wang Y, et al. PIEZO1 mediates matrix stiffness-induced tumor progression in kidney renal clear cell carcinoma by activating the Ca2+/Calpain/YAP pathway. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 2025, 1872(1), 119871. DOI: 10.1016/j.bbamcr.2024.119871

Etem EÖ, Ceylan GG, Özaydın S, Ceylan C, Özercan I, Kuloğlu T. The increased expression of Piezo1 and Piezo2 ion channels in human and mouse bladder carcinoma. Advances in Clinical and Experimental Medicine : Official Organ Wroclaw Medical University. 2018, 27(8), 1025-1031. DOI: 10.17219/acem/71080

Ma MH, Li JP, Li X, Jing MX, Wang L, Jiang YZ, et al. Piezo1/ITGB1 synergizes with Ca2+/YAP signaling to propel bladder carcinoma progression via a stiffness-dependent positive feedback loop. Cancer Medicine. 2025, 14(14), e71059. DOI: 10.1002/cam4.71059

Liang B, Zhang LF, Barbera G, Fang WT, Zhang J, Chen XC, et al. Distinct and dynamic ON and OFF neural ensembles in the prefrontal cortex code social exploration. Neuron. 2018, 100(3), 700-714.e9. DOI: 10.1016/j.neuron.2018.08.043

Qu SQ, Li ST, Hu ZC. Upregulation of Piezo1 is a novel prognostic indicator in glioma patients. Cancer Management and Research. 2020, 12, 3527-3536. DOI: 10.2147/CMAR.S251776

Qu SQ, Hu TY, Qiu OW, Su YJ, Gu JY, Xia ZB. Effect of Piezo1 overexpression on peritumoral brain edema in glioblastomas. American Journal of Neuroradiology. 2020, 41(8), 1423-1429. DOI: 10.3174/ajnr.A6638

Kim OH, Tulip IJ, Kang H, Chang ES, Lee HJ. Compression force promotes glioblastoma progression through the Piezo1‑GDF15‑CTLA4 axis. Oncology Reports. 2024, 53(1), 2. DOI: 10.3892/or.2024.8835

Chen MJ, Liu YQ, Zuo MZ, Guo CH, Du YK, Xu HF, et al. NEDD8 enhances Hippo signaling by mediating YAP1 neddylation. The Journal of Biological Chemistry. 2024, 300(8), 107512. DOI: 10.1016/j.jbc.2024.107512

Zhang N, Wu PF, Mu ML, Niu CS, Hu SS. Exosomal circZNF800 derived from glioma stem-like cells regulates glioblastoma tumorigenicity via the PIEZO1/Akt axis. Molecular Neurobiology. 2024, 61(9), 6556-6571. DOI: 10.1007/s12035-024-04002-0

Gillespie SM, Seok Kim Y, Geraghty AC, Yalçın B, Mancusi R, Hysinger J, et al. Neuroligin-3 interaction with CSPG4 regulates normal and malignant glial precursors through PIEZO1. BioRxiv: the Preprint Server for Biology. 2025. DOI: 10.1101/2025.07.12.664340

Blanco-Carlon P, Navarro Aguadero MA, Aguilar-Garrido P, Otero-Sobrino A, Hernández-Sánchez M, Barea AA, et al. The mechanoreceptor PIEZO1 is a novel oncogene in glioma by promoting astrocyte reactivity. BioRxiv. 2024. DOI: 10.1101/2024.04.30.591858

Michelucci A, Sforna L, Battista AD, Franciolini F, Catacuzzeno L. Ca2+-activated K+ channels regulate cell volume in human glioblastoma cells. Journal of Cellular Physiology. 2023, 238(9), 2120-2134. DOI: 10.1002/jcp.31072

Knoblauch SV, Desai SH, Dombroski JA, Sarna NS, Hope JM, King MR. Chemical activation and mechanical sensitization of Piezo1 enhance TRAIL-mediated apoptosis in glioblastoma cells. ACS Omega. 2023, 8(19), 16975-16986. DOI: 10.1021/acsomega.3c00705

Zhang SM, Cao S, Gong MY, Zhang WN, Zhang WF, Zhu Z, et al. Mechanically activated ion channel Piezo1 contributes to melanoma malignant progression through AKT/mTOR signaling. Cancer Biology & Therapy. 2022, 23(1), 336-347. DOI: 10.1080/15384047.2022.2060015

Silvani G, Kopecky C, Romanazzo S, Rodríguez V, Das A, Pandzic E, et al. Capillary constrictions prime cancer cell tumorigenicity through PIEZO1. Nature Communications. 2025, 16(1), 8160. DOI: 10.1038/s41467-025-63374-6

Kuang S, Abrenica A, Kar N, Logue JS. Targeting cholesterol-dependent Piezo1 activation impairs amoeboid migration in melanoma cells. BioRxiv. 2025. DOI: 10.1101/2025.07.11.664494

Vasileva VY, Khairullina ZM, Chubinskiy-Nadezhdin VI. Piezo1 activation prevents spheroid formation by malignant melanoma SK-MEL-2 Cells. International Journal of Molecular Sciences. 2023, 24(21), 15703. DOI: 10.3390/ijms242115703

Zhu BQ, Qian W, Han CQ, Bai T, Hou XH. Piezo 1 activation facilitates cholangiocarcinoma metastasis via Hippo/YAP signaling axis. Molecular Therapy. Nucleic Acids. 2021, 24, 241-252. DOI: 10.1016/j.omtn.2021.02.026

Pajic-Lijakovic I, Milivojevic M, Martinac B, McClintock PVE. Targeted elimination of mesenchymal-like cancer cells through cyclic stretch activation of Piezo1 channels: the physical aspects. Biophysical Reviews. 2025, 17(3), 847-865. DOI: 10.1007/s12551-025-01304-y

Kuriyama M, Hirose H, Masuda T, Shudou M, Arafiles JVV, Imanishi M, et al. Piezo1 activation using Yoda1 inhibits macropinocytosis in A431 human epidermoid carcinoma cells. Scientific Reports. 2022, 12(1), 6322. DOI: 10.1038/s41598-022-10153-8

Qin X, Ni Z, Jiang JJ, Liu XG, Dong XY, Li M, et al. High-throughput membrane-anchored proteome screening reveals PIEZO1 as a promising antibody-drug target for human esophageal squamous cell carcinoma. Cancer Medicine. 2022, 11(19), 3700-3713. DOI: 10.1002/cam4.4744

Lebon D, Collet L, Djordjevic S, Gomila C, Ouled-Haddou H, Platon J, et al. PIEZO1 is essential for the survival and proliferation of acute myeloid leukemia cells. Cancer Medicine. 2024, 13(2), e6984. DOI: 10.1002/cam4.6984

Vasileva V, Morachevskaya E, Sudarikova A, Negulyaev Y, Chubinskiy-Nadezhdin V. Selective chemical activation of Piezo1 in leukemia cell membrane: single channel analysis. International Journal of Molecular Sciences. 2021, 22(15). DOI: 10.3390/ijms22157839

Nguyen LTP, Kim Y, Hur SS, Byeon HK, Ban MJ, Shim JW, et al. PIEZO1 activation may serve as an early tissue biomarker for the prediction of irradiation-induced salivary gland dysfunction. Biochemical and Biophysical Research Communications. 2024, 727, 150291. DOI: 10.1016/j.bbrc.2024.150291

Sheth M, Sharma M, Kongsomros S, Lehn M, Takebe T, Takiar V, et al. Matrix stiffness modulated release of spheroid-derived extracellular vesicles and discovery of Piezo1 cargo. BioRxiv : the Preprint Server for Biology. 2025. DOI: 10.1101/2025.01.13.632826

Liu TY, Zhou LL, Li DN, Andl T, Zhang YH. Cancer-associated fibroblasts build and secure the tumor microenvironment. Frontiers in Cell and Developmental Biology. 2019, 7, 60. DOI: 10.3389/fcell.2019.00060

Sakthivel K, Kotowska A, Fan ZM, Portner EJ, Merry C, Nordenfelt P, et al. Integrin-Piezo1 axis drives ECM remodeling and invasion of 3D breast epithelium. Advanced Science. 2025, e09932. DOI: 10.1002/advs.202509932

Tu SW, Li YW, Li JY, Ma N, Yao KF, Chen ZH, et al. Mechanical stretch-mediated fibroblast activation: The pivotal role of Piezo1 channels. Biochimica et Biophysica Acta (BBA)-Molecular Cell Research. 2025, 1872(7), 120008. DOI: 10.1016/j.bbamcr.2025.120008

Atcha H, Jairaman A, Holt JR, Meli VS, Nagalla RR, Veerasubramanian PK, et al. Mechanically activated ion channel Piezo1 modulates macrophage polarization and stiffness sensing. Nature Communications. 2021, 12(1), 3256. DOI: 10.1038/s41467-021-23482-5

Wang YX, Yang H, Jia AN, Wang YF, Yang QL, Dong YJ, et al. Dendritic cell Piezo1 directs the differentiation of T(H)1 and T(reg) cells in cancer. Elife. 2022, 11, e79957. DOI: 10.7554/eLife.79957

Qu P, Zhang HY. The dual role of Piezo1 in tumor cells and immune cells: a new target for cancer therapy. Frontiers in Immunology. 2025, 16, 1635388. DOI: 10.3389/fimmu.2025.1635388

Sakthivel K, Kotowska A, Portner EJ, Merry C, Nordenfelt P, Simonsen AC, et al. β1 Integrin-FAK-Piezo1 signalling axis drives in-situ stiffening mediated ECM remodelling and invasion of 3D breast epithelium. BioRxiv. 2025. DOI: 10.1101/2025.01.07.631639

Zhou TF, Gao B, Fan Y, Liu YC, Feng SH, Cong Q, et al. Piezo1/2 mediate mechanotransduction essential for bone formation through concerted activation of NFAT-YAP1-ß-catenin. Elife. 2020, 9, e52779. DOI: 10.7554/eLife.52779

Downloads

Published

2026-01-29

How to Cite

Parisa Beyranvand. (2026). Piezo1-Mediated Mechanotransduction in Cancer: A Comprehensive Up-to-Date Review of Emerging Mechanistic and Therapeutic Insights. Journal of Cancer Biomoleculars and Therapeutics, 3(1), 35–56. Retrieved from https://jcbt.eternopublisher.com/index.php/jcbt/article/view/83